The burden of typhoid fever in low-and middle-income countries: a meta-regression approach M Antillón, JL Warren, FW Crawford, DM Weinberger, E Kürüm, GD Pak, ... PLoS neglected tropical diseases 11 (2), e0005376, 2017 | 331 | 2017 |
Racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysis AM Evens, M Antillón, B Aschebrook-Kilfoy, BCH Chiu Annals of Oncology 23 (8), 2128-2137, 2012 | 109 | 2012 |
The relationship between blood sample volume and diagnostic sensitivity of blood culture for typhoid and paratyphoid fever: a systematic review and meta-analysis M Antillon, NJ Saad, S Baker, AJ Pollard, VE Pitzer The Journal of infectious diseases 218 (suppl_4), S255-S267, 2018 | 90 | 2018 |
Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance JR Andrews, S Baker, F Marks, M Alsan, D Garrett, BG Gellin, SK Saha, ... The Lancet Infectious Diseases 19 (1), e26-e30, 2019 | 78 | 2019 |
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study J Bilcke, M Antillón, Z Pieters, E Kuylen, L Abboud, KM Neuzil, AJ Pollard, ... The Lancet Infectious Diseases 19 (7), 728-739, 2019 | 76 | 2019 |
Sleep behavior and unemployment conditions M Antillón, DS Lauderdale, J Mullahy Economics & Human Biology 14, 22-32, 2014 | 75 | 2014 |
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 … X Li, L Willem, M Antillon, J Bilcke, M Jit, P Beutels BMC medicine 18, 1-16, 2020 | 73 | 2020 |
Seasonal dynamics of typhoid and paratyphoid fever NJ Saad, VD Lynch, M Antillón, C Yang, JA Crump, VE Pitzer Scientific reports 8 (1), 6870, 2018 | 57 | 2018 |
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low-and middle-income settings M Antillón, J Bilcke, AD Paltiel, VE Pitzer Vaccine 35 (27), 3506-3514, 2017 | 56 | 2017 |
Case fatality rate of enteric fever in endemic countries: a systematic review and meta-analysis Z Pieters, NJ Saad, M Antillón, VE Pitzer, J Bilcke Clinical Infectious Diseases 67 (4), 628-638, 2018 | 40 | 2018 |
Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study R Birger, M Antillón, J Bilcke, C Dolecek, G Dougan, AJ Pollard, ... The Lancet Infectious Diseases 22 (5), 679-691, 2022 | 37 | 2022 |
Strategies to prevent cholera introduction during international personnel deployments: a computational modeling analysis based on the 2010 Haiti outbreak JA Lewnard, M Antillón, G Gonsalves, AM Miller, AI Ko, VE Pitzer PLoS medicine 13 (1), e1001947, 2016 | 33 | 2016 |
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models R Baral, X Li, L Willem, M Antillon, A Vilajeliu, M Jit, P Beutels, C Pecenka Vaccine 38 (33), 5139-5147, 2020 | 20 | 2020 |
The importance of thinking beyond the water-supply in cholera epidemics: A historical urban case-study MD Phelps, AS Azman, JA Lewnard, M Antillón, L Simonsen, ... PLoS neglected tropical diseases 11 (11), e0006103, 2017 | 18 | 2017 |
Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad KS Rock, CI Huang, RE Crump, PR Bessell, PE Brown, I Tirados, ... Infectious Diseases of Poverty 11 (01), 34-46, 2022 | 14 | 2022 |
Trends and correlates of cystic echinococcosis in Chile: 2001–2012 S Colombe, E Togami, F Gelaw, M Antillon, R Fuentes, DM Weinberger PLoS Neglected Tropical Diseases 11 (9), e0005911, 2017 | 14 | 2017 |
Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of … CN Davis, KS Rock, M Antillón, EM Miaka, MJ Keeling BMC medicine 19, 1-18, 2021 | 13 | 2021 |
Tracking and predicting US influenza activity with a real-time surveillance network SI Leuba, R Yaesoubi, M Antillon, T Cohen, C Zimmer PLoS computational biology 16 (11), e1008180, 2020 | 13 | 2020 |
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa M Koltai, J Moyes, B Nyawanda, J Nyiro, PK Munywoki, S Tempia, X Li, ... BMC medicine 21 (1), 120, 2023 | 9 | 2023 |
From public health policy to impact for COVID-19: a multi-country case study in Switzerland, Spain, Iran and Pakistan M Tavakkoli, A Karim, FB Fischer, L Monzon Llamas, A Raoofi, S Zafar, ... International journal of public health 67, 1604969, 2022 | 9 | 2022 |